Tests to identify chromosomal abnormalities in embryos and in early pregnancies are frequently used to make important decisions, including terminations, but many rely on outdated science. Regulation of these genetic tests is urgently needed to ensure transparency and validation.
This is a preview of subscription content
Subscribe to Nature+
Get immediate online access to the entire Nature family of 50+ journals
Subscribe to Journal
Get full journal access for 1 year
only $4.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Gleicher, N., Patrizio, P. & Brivanlou, A. Trends Mol. Med. 27, 731–742 (2021).
Mastenbroek, S., de Wert, G. & Adashi, E. Y. N. Engl. J. Med. 385, 2096–2100 (2021).
Chatzimeletiou, K. et al. Zygote 15, 81–90 (2007).
Chatzimeletiou, K. et al. Hum. Reprod. 20, 672–682 (2005).
Ottolini, C. S. et al. Sci. Rep. 7, 9744 (2017).
Coticchio, G. et al. Hum. Reprod. Update 27, 848–856 (2021).
Kiessling, A. A. et al. J. Assist. Reprod. Genet. 27, 265–276 (2010).
Lee, A. & Kiessling, A. A. J. Assist. Reprod. Genet. 34, 15–21 (2017).
Coorens, T. H. H. et al. Nature 592, 80–85 (2021).
Costello, J. F. & Fisher, S. J. N. Engl. J. Med. 385, 87–89 (2021).
Park, S. et al. Nature 597, 393–397 (2021).
Yang, M. et al. Nat. Cell Biol. 23, 314–321 (2021).
Gamage, T. K. J. B. et al. Biol. Open 7, bio034884 (2018).
Gleicher, N., Deppe, G. & Cohen, C. J. Obstet. Gynecol. 54, 335–342 (1979).
Popovic, M. et al. Hum. Reprod. Update 26, 312–334 (2020).
Starostik, M. R., Sosina, O. A. & McCoy, R. C. Genome Res. 30, 814–825 (2020).
Lee, J.-M. et al. Mol. Diagn. Ther. 25, 351–359 (2021).
Gleicher, N., Weghofer, A. & Barad, D. H. Autoimmun. Rev. 10, 361–363 (2011).
Hanson, B. M. et al. Fertil. Steril. 115, 1461–1470 (2021).
Orvieto, R., Aizer, A. & Gleicher, N. Hum. Reprod. 36, 1186–1190 (2021).
Kliff, S. & Bhatia, A. When they warn of rare disorders, these prenatal tests are usually wrong. The New York Times (January 2022).
Yan, J. et al. N. Engl. J. Med. 385, 2047–2058 (2021).
Turley, P. et al. N. Engl. J. Med. 385, 78–86 (2021).
Lencz, T. et al. eLife 10, e64716 (2021).
Polygenic Risk Score Task Force of the International Common Disease Alliance. Nat. Med. 27, 1876-1884 (2021).
Forzano, F. et al. Eur. J. Hum. Genet. https://doi.org/10.1038/s41431-021-01000-x (2021).
N.G. is listed as co-inventor on several U.S. patents and receives royalties from Fertility Nutraceuticals LLC, New York, NY, for some of these patents, none of which relate to subjects discussed in this article. N.G. is a shareholder in Fertility Nutraceuticals, owns The Center for Human Reproduction (CHR), a fertility center in New York, NY, and received speaker honoraria and research grant support from Ferring Pharmaceuticals (Saint-Prex, Switzerland) and Cook Medical (Bloomington, IN). D.F.A. receives as editor-in-chief of a medical journal a stipend from Springer Nature, and in 2021 received speaker honoraria from EMD Serono (Rockland, MA) and Cook Medical (Bloomington, IN). R.O. received speaker honoraria from Ferring Pharmaceuticals (Saint-Prex, Switzerland) and Merck KGaA. (Darmstadt, Germany). All other authors have no conflicts to report.
About this article
Cite this article
Gleicher, N., Albertini, D.F., Patrizio, P. et al. The uncertain science of preimplantation and prenatal genetic testing. Nat Med 28, 442–444 (2022). https://doi.org/10.1038/s41591-022-01712-7